You are here: Industry Insights > cancer

News List

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035 drugs
May 10, 2019
ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035.
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer worldpharmanews
May 10, 2019
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer.
Prostate cancer mutation found to triple risk of death pharmatimes
May 09, 2019
Prostate cancer mutation found to triple risk of death.
Raman scattering for non-invasive prostate cancer screening europeanpharmaceuticalreview
May 07, 2019
Raman scattering for non-invasive prostate cancer screening.
Novartis & Bristol-Myers Squibb to collaborate on cancer treatments europeanpharmaceuticalreview
May 07, 2019
Novartis has entered into a research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist…
New imaging technique may predict the spread of breast cancer europeanpharmaceuticalreview
May 06, 2019
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung…
Z-endoxifen shows promise for breast cancer europeanpharmaceuticalreview
May 06, 2019
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer…
Good news for AZ's 'next phase of growth': Its cancer drugs have shifted into high gear fiercepharma
May 06, 2019
For the first time, AstraZeneca's top-selling medicine isn't a stomach drug or a respiratory inhaler or any other primary care med. It's a cancer drug.
MRI effective in detecting postpartum breast cancers europeanpharmaceuticalreview
May 06, 2019
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI…
ALA-artemisinin combination therapy for cancer identified europeanpharmaceuticalreview
May 06, 2019
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…